Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Single agent, canfosfamide (C, TLK286) vs pegylated liposomal doxorubicin (D) or topotecan (T) in 3rd-line treatment of platinum (P) refractory or resistant ovarian cancer (OC): phase 3 study results [Abstract]
On Day 0, each rabbit underwent a surgical procedure to create two full-thickness open wounds
doi: 10.3390/nu17030405 110 HughesRLAlvaradoDASwansonKSHolscherHD
Khorram, O., Laughlin, G
G.IlhanZ
ACSL1 enhances antioxidant capacity and inhibits tumor cell ferroptosis by regulating FSP1 myristoylation, thereby inducing platinum resistance [271]
US$ 24.47
US$ 21.69
US$ 21.40
US$ 25.27
